CEOs are Hesitant to Speak Out On Political Matters Affecting their Industries, Says Health Policy Analyst Dr. David Hogberg Who Wants to Risk an IRS Audit or Worse? Plainsboro, NJ/Washington DC – Asked at his company’s annual shareholder meeting whether the federal government is sufficiently … Continue reading Bristol-Myers Squibb CEO Ducks Question About Political Meddling in Drug Pricing at Annual Shareholder Meeting